P-32 bremsstrahlung SPECT helps assess intracavitary therapy

B. Petri, Robert Nance, J. Hanada, Jeffrey Stevens

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

A patient underwent intracavitary P-32 chromic phosphate therapy for a chest tumor. Tc-99m sulfur colloid instilled before the P-32 demonstrated uniform distribution of activity throughout the right pleural space, and the P-32 was immediately administered. Ten days later, SPECT imaging using bremsstrahlung radiation of the P-32 showed an unexpected loculation of the P-32. A subsequent chest CT scan demonstrated pleural infolding and fluid localization in the same area as the P-32, indicating that the bremsstrahlung SPECT study had, in fact, documented the final localization of the P-32, which was unexpected and different from the initial localization. The procedure used in this case may be of value in documenting the ultimate distribution of intracavitary P-32.

Original languageEnglish (US)
Pages (from-to)709-710
Number of pages2
JournalClinical Nuclear Medicine
Volume17
Issue number9
DOIs
StatePublished - 1992

Fingerprint

Single-Photon Emission-Computed Tomography
Thorax
Technetium Tc 99m Sulfur Colloid
Radiation
Therapeutics
Neoplasms
chromic phosphate

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

P-32 bremsstrahlung SPECT helps assess intracavitary therapy. / Petri, B.; Nance, Robert; Hanada, J.; Stevens, Jeffrey.

In: Clinical Nuclear Medicine, Vol. 17, No. 9, 1992, p. 709-710.

Research output: Contribution to journalArticle

Petri, B. ; Nance, Robert ; Hanada, J. ; Stevens, Jeffrey. / P-32 bremsstrahlung SPECT helps assess intracavitary therapy. In: Clinical Nuclear Medicine. 1992 ; Vol. 17, No. 9. pp. 709-710.
@article{3e69513e2b504a549b7b4b2c357d17a9,
title = "P-32 bremsstrahlung SPECT helps assess intracavitary therapy",
abstract = "A patient underwent intracavitary P-32 chromic phosphate therapy for a chest tumor. Tc-99m sulfur colloid instilled before the P-32 demonstrated uniform distribution of activity throughout the right pleural space, and the P-32 was immediately administered. Ten days later, SPECT imaging using bremsstrahlung radiation of the P-32 showed an unexpected loculation of the P-32. A subsequent chest CT scan demonstrated pleural infolding and fluid localization in the same area as the P-32, indicating that the bremsstrahlung SPECT study had, in fact, documented the final localization of the P-32, which was unexpected and different from the initial localization. The procedure used in this case may be of value in documenting the ultimate distribution of intracavitary P-32.",
author = "B. Petri and Robert Nance and J. Hanada and Jeffrey Stevens",
year = "1992",
doi = "10.1097/00003072-199209000-00004",
language = "English (US)",
volume = "17",
pages = "709--710",
journal = "Clinical Nuclear Medicine",
issn = "0363-9762",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - P-32 bremsstrahlung SPECT helps assess intracavitary therapy

AU - Petri, B.

AU - Nance, Robert

AU - Hanada, J.

AU - Stevens, Jeffrey

PY - 1992

Y1 - 1992

N2 - A patient underwent intracavitary P-32 chromic phosphate therapy for a chest tumor. Tc-99m sulfur colloid instilled before the P-32 demonstrated uniform distribution of activity throughout the right pleural space, and the P-32 was immediately administered. Ten days later, SPECT imaging using bremsstrahlung radiation of the P-32 showed an unexpected loculation of the P-32. A subsequent chest CT scan demonstrated pleural infolding and fluid localization in the same area as the P-32, indicating that the bremsstrahlung SPECT study had, in fact, documented the final localization of the P-32, which was unexpected and different from the initial localization. The procedure used in this case may be of value in documenting the ultimate distribution of intracavitary P-32.

AB - A patient underwent intracavitary P-32 chromic phosphate therapy for a chest tumor. Tc-99m sulfur colloid instilled before the P-32 demonstrated uniform distribution of activity throughout the right pleural space, and the P-32 was immediately administered. Ten days later, SPECT imaging using bremsstrahlung radiation of the P-32 showed an unexpected loculation of the P-32. A subsequent chest CT scan demonstrated pleural infolding and fluid localization in the same area as the P-32, indicating that the bremsstrahlung SPECT study had, in fact, documented the final localization of the P-32, which was unexpected and different from the initial localization. The procedure used in this case may be of value in documenting the ultimate distribution of intracavitary P-32.

UR - http://www.scopus.com/inward/record.url?scp=0026785094&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026785094&partnerID=8YFLogxK

U2 - 10.1097/00003072-199209000-00004

DO - 10.1097/00003072-199209000-00004

M3 - Article

C2 - 1395341

AN - SCOPUS:0026785094

VL - 17

SP - 709

EP - 710

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

IS - 9

ER -